Porteous M, Dunckley M, Appleton S, Catt S, Dunlop M, Campbell H, Cull A
Department of Clinical Genetics, Molecular Medicine Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.
Br J Cancer. 2003 Oct 20;89(8):1400-2. doi: 10.1038/sj.bjc.6601332.
In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.
在这项试点研究中,评估了向111名新诊断出的结直肠癌患者提供遗传性非息肉病性结直肠癌(HNPCC)基因检测的可接受性。共有78%的参与者认为在那个时候让他们了解HNPCC的信息是非常可以接受的。